Why the study?
Are local carotid stiffness and inflammatory biomarkers (hsCRP, fibrinogen) associated with the presence and extent of CAD in patients with stable angina pectoris?
Are local carotid stiffness and inflammatory biomarkers (hsCRP, fibrinogen) associated with the presence and extent of CAD in patients with stable angina pectoris?
Local carotid stiffness, carotid IMT, hsCRP, and fibrinogen levels are independent predictors of atherosclerotic burden in patients with stable angina pectoris.
Hypothesis-generating for carotid stiffness and inflammation links in SAP; larger prospective studies needed before clinical adoption.
INTRODUCTION: Arterial stiffness (AS) is a well-accepted and reliable predictor of atherosclerotic diseases. Inflammation plays an important role in the development of AS. AIM: To evaluate local carotid stiffness (CS) together with fibrinogen and high-sensitivity C-reactive protein (hsCRP) levels in stable angina pectoris (SAP) patients. MATERIAL AND METHODS: = 68). RESULTS: = 0.001). Significant correlations were observed between both inflammatory biomarkers and the number of diseased vessels and carotid PWV. Using multi-variate analysis, carotid stiffness, carotid IMT, hsCRP and fibrinogen were independently associated with the presence and extent of CAD. CONCLUSIONS: Local CS, carotid IMT, hsCRP and fibrinogen levels are significant predictors of atherosclerotic burden and they may facilitate the identification of high-risk patients for the early diagnosis and prompt treatment of CAD.
No takes yet. Share an insight, caveat, or question.
Aslan et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: